MANAGED ACCOUNT ADVISORS LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2015. The put-call ratio across all filers is 3.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANAGED ACCOUNT ADVISORS LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$15,586,000
-11.6%
368,826
-18.8%
0.01%
-13.3%
Q1 2015$17,624,000
-40.0%
454,474
-47.9%
0.02%
-48.3%
Q4 2014$29,377,000
+17.7%
872,480
+22.5%
0.03%
+3.6%
Q3 2014$24,949,000
+68.7%
712,422
+58.3%
0.03%
+55.6%
Q2 2014$14,786,000
+16.0%
449,974
+30.1%
0.02%
+5.9%
Q1 2014$12,747,000
+7.1%
345,832
+11.5%
0.02%
+6.2%
Q4 2013$11,904,000
+303.7%
310,158
+188.2%
0.02%
+300.0%
Q3 2013$2,949,000
+21.5%
107,632
-6.9%
0.00%0.0%
Q2 2013$2,428,000115,6220.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders